Nila Spaces Limited (NSE:NILASPACES)

Verve Therapeutics Revenue

In the fiscal year ending March 31, 2025, Nila Spaces had annual revenue of 1.36B INR with 49.70% growth. Nila Spaces had revenue of 397.61M in the quarter ending March 31, 2025, with 23.13% growth.

• Revenue: 1.36B
• Revenue Growth: +49.70%
• P/S Ratio: 3.86
• Revenue / Employee: 79.88M
• Employees: 17
• Market Cap: 5.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	1.36B	450.85M	49.70%
Mar 31, 2024	907.14M	897.03M	8,874.44%
Mar 31, 2023	10.11M	-43.16M	-81.02%
Mar 31, 2022	53.27M	-397.97M	-88.19%
Mar 31, 2021	451.24M	-425.26M	-48.52%